1. Home
  2. VRDN vs KYIV Comparison

VRDN vs KYIV Comparison

Compare VRDN & KYIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$31.17

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

KYIV

Kyivstar Group Ltd.

N/A

Current Price

$12.75

Market Cap

3.1B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VRDN
KYIV
Founded
2006
N/A
Country
United States
United Arab Emirates
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VRDN
KYIV
Price
$31.17
$12.75
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
$40.45
N/A
AVG Volume (30 Days)
1.4M
N/A
Earning Date
11-05-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,789,000.00
N/A
Revenue This Year
$26,257.62
N/A
Revenue Next Year
$10.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
23340.07
N/A
52 Week Low
$9.90
N/A
52 Week High
$34.04
N/A

Technical Indicators

Market Signals
Indicator
VRDN
KYIV
Relative Strength Index (RSI) 50.76 N/A
Support Level $30.57 N/A
Resistance Level $32.92 N/A
Average True Range (ATR) 0.98 0.00
MACD -0.39 0.00
Stochastic Oscillator 19.02 0.00

Price Performance

Historical Comparison
VRDN
KYIV

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About KYIV Kyivstar Group Ltd.

Kyivstar Group Ltd is engaged in mobile communication.

Share on Social Networks: